Waseem Sharieff
McMaster University, Dalhousie University, Juravinski Cancer Centre
Papers
3
Total Citations
76
H-Index
3
About
Waseem Sharieff is a leading clinical researcher in neuro-oncology and stereotactic radiosurgery, with a focused expertise in the management of aggressive brain tumors and the economic evaluation of advanced radiotherapy techniques. His most impactful work addresses the formidable challenge of locally recurrent glioblastoma multiforme (GBM). In his highly cited prospective cohort study (56 citations), Sharieff demonstrated that combining fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy offers a significant salvage response with acceptable toxicity—a critical contribution given the limited efficacy of standard options for recurrent GBM. Beyond neuro-oncology, Sharieff has advanced the field of prostate cancer treatment, contributing foundational work on the technique, resources, and costs of stereotactic body radiotherapy (SBRT). He has also pioneered pragmatic health-economic frameworks, applying cost-benefit analysis and willingness-to-pay models to robotic radiosurgery for brain metastases, ensuring that technological innovation is balanced with patient preferences and community resource allocation. His work bridges clinical efficacy with real-world economic sustainability, making him a key voice in the rational adoption of high-precision radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3